Header Logo

Connection

ERIC SCHAFER to TOR Serine-Threonine Kinases

Back to Details
This is a "connection" page, showing publications ERIC SCHAFER has written about TOR Serine-Threonine Kinases.
ERIC SCHAFER
Connection Strength
0.042
TOR Serine-Threonine Kinases
  1. Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001). Haematologica. 2022 10 01; 107(10):2295-2303.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.